论文部分内容阅读
目的探讨分析米非司酮治疗子宫肌瘤的效果。方法随机抽取2007-01-2008-01吉林市第二中心医院妇科门诊收治的100例子宫肌瘤患者的临床资料,50例口服肌瘤汤,为对照组,50例口服米非司酮,为试验组,进行比较分析。结果两组总有效率比较,米非司酮治疗子宫肌瘤的效果较好。试验组治疗后6个月肌瘤面积持续缩小,两组红细胞沉降率、血细胞压积、高切全血黏度下降差别显著,具有统计学意义。结论米非司酮是一种安全、有效的药物。
Objective To investigate the effect of mifepristone in treating uterine fibroids. Methods The clinical data of 100 cases of uterine fibroids treated in gynecology outpatient department of the Second Central Hospital of Jilin City from 2007-01-2008-01 were randomly selected. Fifty patients with oral myoma of fibroids were served as the control group and 50 cases were given mifepristone as Test group, comparative analysis. Results The total effective rate of two groups, mifepristone treatment of uterine fibroids better. The area of fibroids continued to decrease at 6 months after the treatment in experimental group. There was significant difference between the two groups in erythrocyte sedimentation rate, hematocrit, and high cut whole blood viscosity, with statistical significance. Conclusion Mifepristone is a safe and effective drug.